Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-19750CALL0 0153.41TRUE00
2025-09-19800CALL0 0152.51TRUE00
2025-09-19850CALL0 0126.39TRUE00
2025-09-19900CALL0 0129.01TRUE00
2025-09-19950CALL0 0127.07TRUE00
2025-09-191000CALL0 0107.3TRUE00
2025-09-191050CALL0 0107.3TRUE00
2025-09-191100CALL0 098.03TRUE00
2025-09-191150CALL0 089.08TRUE00
2025-09-191200CALL0 080.36TRUE00
2025-09-1912563.5CALL0 079.59TRUE00
2025-09-191300CALL0 071.84TRUE00
2025-09-191350CALL0 069.44TRUE00
2025-09-1914035.5CALL0 157.04TRUE00
2025-09-191450CALL0 055.44TRUE00
2025-09-1915028CALL0 191.63TRUE00
2025-09-1915524.55CALL0 150.64TRUE00
2025-09-1916036.2CALL0 142.14TRUE00
2025-09-1916522.6CALL0 142.14TRUE00
2025-09-1917025.67CALL1 26246.42TRUE25.670
2025-09-1917514.13CALL0 1044.45TRUE00
2025-09-191807.85CALL0 6844.32TRUE00
2025-09-1918513.8CALL0 34742.22TRUE00
2025-09-1919013.88CALL0 1242.76TRUE00
2025-09-191959.1CALL0 641.24FALSE00
2025-09-192004.38CALL0 22339.17FALSE00
2025-09-192102CALL0 1637.79FALSE00
2025-09-192201.5CALL0 844.98FALSE00
2025-09-192301.1CALL0 653.44FALSE00
2025-09-192400.5CALL0 15062.37FALSE00
2025-09-192500.8CALL0 171.2FALSE00
2025-09-192600.35CALL0 179.42FALSE00
2025-09-19750PUT0 0234.59FALSE00
2025-09-19800PUT0 0220.15FALSE00
2025-09-19850PUT0 0206.62FALSE00
2025-09-19900PUT0 0193.87FALSE00
2025-09-19950PUT0 0181.82FALSE00
2025-09-191000PUT0 0170.38FALSE00
2025-09-191050PUT0 0159.48FALSE00
2025-09-191100PUT0 0149.07FALSE00
2025-09-191150PUT0 0139.09FALSE00
2025-09-191200PUT0 0129.51FALSE00
2025-09-191251.85PUT0 1120.27FALSE00
2025-09-191302.4PUT0 2111.34FALSE00
2025-09-191351.08PUT0 1102.69FALSE00
2025-09-191401.13PUT0 094.29FALSE00
2025-09-191454.9PUT0 186.1FALSE00
2025-09-191503PUT0 101978.1FALSE00
2025-09-191550.9PUT0 1271.07FALSE00
2025-09-191601PUT0 2164.73FALSE00
2025-09-191651.56PUT0 22955.61FALSE00
2025-09-191702.4PUT0 25850.35FALSE00
2025-09-191752.03PUT10 1749.21FALSE2.030
2025-09-191804.09PUT0 157847.41FALSE00
2025-09-191854.56PUT10 2048.29FALSE4.560
2025-09-191907.41PUT0 747.34FALSE00
2025-09-1919510.5PUT0 242.89TRUE00
2025-09-1920014.59PUT0 041.27TRUE00
2025-09-1921018.04PUT0 537.89TRUE00
2025-09-1922033.7PUT0 038.41TRUE00
2025-09-192300PUT0 067.33TRUE00
2025-09-192400PUT0 078.25TRUE00
2025-09-192500PUT0 088.32TRUE00
2025-09-192600PUT0 097.69TRUE00
2025-10-17750CALL0 0166.57TRUE00
2025-10-17800CALL0 0151.71TRUE00
2025-10-1785103.5CALL0 0145.87TRUE00
2025-10-17900CALL0 0138.29TRUE00
2025-10-17950CALL0 0129.36TRUE00
2025-10-171000CALL0 0120.9TRUE00
2025-10-171050CALL0 0114.42TRUE00
2025-10-171100CALL0 0106.71TRUE00
2025-10-171150CALL0 099.34TRUE00
2025-10-171200CALL0 093.6TRUE00
2025-10-171250CALL0 052.94TRUE00
2025-10-171300CALL0 052.39TRUE00
2025-10-171350CALL0 050.65TRUE00
2025-10-171400CALL0 048.26TRUE00
2025-10-171450CALL0 047.46TRUE00
2025-10-171500CALL0 043.26TRUE00
2025-10-1715542.6CALL0 043.12TRUE00
2025-10-171600CALL0 044.34TRUE00
2025-10-171650CALL0 044.39TRUE00
2025-10-1717021.5CALL0 644.25TRUE00
2025-10-1717526.1CALL0 144.78TRUE00
2025-10-1718022.35CALL0 543.74TRUE00
2025-10-1718519.2CALL0 243.04TRUE00
2025-10-1719015.8CALL0 1543.23TRUE00
2025-10-171959.93CALL0 1042.77FALSE00
2025-10-1720010.45CALL0 36942.05FALSE00
2025-10-172104.9CALL0 6239.99FALSE00
2025-10-172203CALL1 21237.69FALSE30
2025-10-172302.78CALL0 340.77FALSE00
2025-10-172401.5CALL0 441.06FALSE00
2025-10-172501.4CALL0 245.72FALSE00
2025-10-172601.1CALL0 450.8FALSE00
2025-10-17750PUT0 0151.9FALSE00
2025-10-17800PUT0 0142.57FALSE00
2025-10-17850PUT0 0133.84FALSE00
2025-10-17900PUT0 0125.61FALSE00
2025-10-17950PUT0 0117.83FALSE00
2025-10-171000PUT0 0110.44FALSE00
2025-10-171050PUT0 1103.41FALSE00
2025-10-171100PUT0 196.69FALSE00
2025-10-171150PUT0 090.25FALSE00
2025-10-171201.85PUT0 184.07FALSE00
2025-10-171252.45PUT0 278.1FALSE00
2025-10-171302.9PUT0 372.71FALSE00
2025-10-171351.43PUT0 067.45FALSE00
2025-10-171400PUT0 062.61FALSE00
2025-10-171450.8PUT0 158.11FALSE00
2025-10-171500PUT0 054.11FALSE00
2025-10-171552.49PUT0 150.88FALSE00
2025-10-171600PUT0 047.91FALSE00
2025-10-171654.19PUT0 145.35FALSE00
2025-10-171709.1PUT0 30046.53FALSE00
2025-10-1717510.9PUT0 044.73FALSE00
2025-10-171806.3PUT0 20044.73FALSE00
2025-10-171850PUT0 044.78FALSE00
2025-10-1719010.57PUT15 1047.02FALSE10.570
2025-10-171950PUT0 044.09TRUE00
2025-10-1720016.52PUT0 042.84TRUE00
2025-10-172100PUT0 041.19TRUE00
2025-10-172200PUT0 039.86TRUE00
2025-10-1723051PUT0 138.67TRUE00
2025-10-1724070PUT0 035.66TRUE00
2025-10-172500PUT0 043.95TRUE00
2025-10-172600PUT0 049.26TRUE00
2025-12-19600CALL0 086.39TRUE00
2025-12-19650CALL0 079.38TRUE00
2025-12-19700CALL0 077.31TRUE00
2025-12-19750CALL0 174.73TRUE00
2025-12-19800CALL0 069.17TRUE00
2025-12-19850CALL0 097.84TRUE00
2025-12-19900CALL0 064TRUE00
2025-12-19950CALL0 062.87TRUE00
2025-12-191000CALL0 059.83TRUE00
2025-12-1910589CALL0 159.06TRUE00
2025-12-191100CALL0 059.25TRUE00
2025-12-191150CALL0 056.49TRUE00
2025-12-191200CALL0 056.55TRUE00
2025-12-191250CALL0 3855.76TRUE00
2025-12-191300CALL0 155.54TRUE00
2025-12-191350CALL0 153.38TRUE00
2025-12-191400CALL0 352.46TRUE00
2025-12-1914545.54CALL0 252.79TRUE00
2025-12-1915037.5CALL0 252.38TRUE00
2025-12-191550CALL0 051.62TRUE00
2025-12-191600CALL0 6651.44TRUE00
2025-12-1916541CALL0 950.25TRUE00
2025-12-1917035.4CALL0 7149.7TRUE00
2025-12-1917531.9CALL0 548.83TRUE00
2025-12-1918028.8CALL0 8648.32TRUE00
2025-12-1918526.1CALL0 1947.47TRUE00
2025-12-1919023.7CALL0 647.05TRUE00
2025-12-1919521.1CALL0 6246.17FALSE00
2025-12-1920021CALL0 21345.57FALSE00
2025-12-1921017.9CALL0 8643.84FALSE00
2025-12-1922010.4CALL0 6542.97FALSE00
2025-12-192305CALL0 141.04FALSE00
2025-12-192406CALL0 539.62FALSE00
2025-12-192504.3CALL0 838.44FALSE00
2025-12-192603.2CALL0 1037FALSE00
2025-12-192702.15CALL0 838.67FALSE00
2025-12-192801.45CALL0 640.6FALSE00
2025-12-192900.95CALL0 342.87FALSE00
2025-12-19600PUT0 0121.89FALSE00
2025-12-19650PUT0 1114.19FALSE00
2025-12-19700PUT0 0107.1FALSE00
2025-12-19750PUT0 0100.52FALSE00
2025-12-19800PUT0 2094.39FALSE00
2025-12-19850PUT0 188.65FALSE00
2025-12-19900PUT0 2183.61FALSE00
2025-12-19950PUT0 178.82FALSE00
2025-12-191000PUT0 174.59FALSE00
2025-12-191052.1PUT0 370.8FALSE00
2025-12-191102.65PUT0 467.1FALSE00
2025-12-191150.6PUT0 063.98FALSE00
2025-12-191200.85PUT0 261.06FALSE00
2025-12-191250PUT0 162.43FALSE00
2025-12-191300PUT0 156.01FALSE00
2025-12-191350PUT0 157.5FALSE00
2025-12-191409.23PUT0 7653.63FALSE00
2025-12-191450PUT0 152.64FALSE00
2025-12-191500PUT0 053.11FALSE00
2025-12-191550PUT0 051.93FALSE00
2025-12-191600PUT0 050.88FALSE00
2025-12-191650PUT0 050.84FALSE00
2025-12-1917010.5PUT0 11550.1FALSE00
2025-12-191750PUT0 049.06FALSE00
2025-12-191800PUT0 048.39FALSE00
2025-12-1918527.5PUT0 16647.64FALSE00
2025-12-191900PUT0 046.45FALSE00
2025-12-1919518.9PUT0 1146.49TRUE00
2025-12-1920030.4PUT0 1745.82TRUE00
2025-12-192100PUT0 144.4TRUE00
2025-12-1922051.9PUT0 343.29TRUE00
2025-12-192300PUT0 041.36TRUE00
2025-12-192400PUT0 139.97TRUE00
2025-12-192500PUT0 038.68TRUE00
2025-12-1926077.4PUT0 035.7TRUE00
2025-12-192700PUT0 051.43TRUE00
2025-12-192800PUT0 055.34TRUE00
2025-12-192900PUT0 059.04TRUE00
2026-01-16750CALL0 0100.36TRUE00
2026-01-16800CALL0 094.55TRUE00
2026-01-16850CALL0 062.7TRUE00
2026-01-16900CALL0 060.86TRUE00
2026-01-16950CALL0 058.75TRUE00
2026-01-161000CALL0 057.45TRUE00
2026-01-161050CALL0 055.75TRUE00
2026-01-161100CALL0 055.09TRUE00
2026-01-161150CALL0 053.88TRUE00
2026-01-161200CALL0 050.92TRUE00
2026-01-161250CALL0 051.24TRUE00
2026-01-161300CALL0 051.1TRUE00
2026-01-1613545.5CALL0 150.61TRUE00
2026-01-161400CALL0 049.64TRUE00
2026-01-161450CALL0 049.76TRUE00
2026-01-1615037.5CALL0 049.84TRUE00
2026-01-161550CALL0 049.7TRUE00
2026-01-1616035.98CALL0 649.08TRUE00
2026-01-1616524.85CALL0 2148.36TRUE00
2026-01-1617037CALL0 21147.78TRUE00
2026-01-1617525.7CALL0 647.69TRUE00
2026-01-1618035.2CALL0 447.06TRUE00
2026-01-1618529.65CALL0 1646.29TRUE00
2026-01-1619025.5CALL0 845.71TRUE00
2026-01-1619522.9CALL0 945.1FALSE00
2026-01-1620023.1CALL0 2244.65FALSE00
2026-01-1621016.4CALL0 443.41FALSE00
2026-01-162209.5CALL0 042.13FALSE00
2026-01-162308.06CALL5 42139.09FALSE-0.74-0.08
2026-01-162407CALL0 75140.04FALSE00
2026-01-162504.83CALL0 338.06FALSE00
2026-01-162600CALL0 036.75FALSE00
2026-01-162700CALL0 035.71FALSE00
2026-01-162802.6CALL0 337.05FALSE00
2026-01-162901.25CALL0 338.55FALSE00
2026-01-16750PUT0 090.09FALSE00
2026-01-16800PUT0 084.99FALSE00
2026-01-16850PUT0 080.18FALSE00
2026-01-16900PUT0 075.64FALSE00
2026-01-16950PUT0 071.62FALSE00
2026-01-161000PUT0 067.77FALSE00
2026-01-161050PUT0 064.32FALSE00
2026-01-161100PUT0 060.95FALSE00
2026-01-161150PUT0 058.31FALSE00
2026-01-161200PUT0 055.63FALSE00
2026-01-161250PUT0 053.27FALSE00
2026-01-161300PUT0 551.29FALSE00
2026-01-161355.23PUT0 2750.38FALSE00
2026-01-161403.78PUT0 1951.39FALSE00
2026-01-161450PUT0 1449.57FALSE00
2026-01-1615010.9PUT0 849.47FALSE00
2026-01-161557.1PUT0 148.77FALSE00
2026-01-1616012.25PUT0 248.43FALSE00
2026-01-161659.58PUT0 3748.07FALSE00
2026-01-1617020.3PUT0 947.68FALSE00
2026-01-1617526.1PUT0 147.12FALSE00
2026-01-1618015.4PUT0 646.87FALSE00
2026-01-1618527.9PUT0 545.99FALSE00
2026-01-1619032.1PUT0 245.85FALSE00
2026-01-1619523.7PUT0 844.89TRUE00
2026-01-1620025.6PUT0 844.4TRUE00
2026-01-1621028.6PUT0 143.57TRUE00
2026-01-162200PUT0 043.3TRUE00
2026-01-162300PUT0 042.48TRUE00
2026-01-162400PUT0 040.78TRUE00
2026-01-162500PUT0 038.42TRUE00
2026-01-162600PUT0 036.85TRUE00
2026-01-162700PUT0 047.33TRUE00
2026-01-162800PUT0 050.91TRUE00
2026-01-162900PUT0 054.3TRUE00
2026-04-171000CALL0 049.4TRUE00
2026-04-171050CALL0 049.38TRUE00
2026-04-171100CALL0 050.5TRUE00
2026-04-171150CALL0 050.43TRUE00
2026-04-171200CALL0 049.62TRUE00
2026-04-171250CALL0 049.38TRUE00
2026-04-171300CALL0 049.5TRUE00
2026-04-171350CALL0 049.67TRUE00
2026-04-171400CALL0 049.4TRUE00
2026-04-171450CALL0 049.08TRUE00
2026-04-171500CALL0 049.21TRUE00
2026-04-171550CALL0 048.64TRUE00
2026-04-171600CALL0 048.58TRUE00
2026-04-171650CALL0 048.44TRUE00
2026-04-171700CALL0 048.12TRUE00
2026-04-1717542.5CALL0 547.56TRUE00
2026-04-171800CALL0 047.13TRUE00
2026-04-171850CALL0 046.66TRUE00
2026-04-171900CALL0 046.32TRUE00
2026-04-171950CALL0 045.75FALSE00
2026-04-172000CALL0 045.15FALSE00
2026-04-172100CALL0 044.15FALSE00
2026-04-172200CALL0 042.99FALSE00
2026-04-1723017.4CALL0 141.94FALSE00
2026-04-172400CALL0 041.02FALSE00
2026-04-172500CALL0 039.66FALSE00
2026-04-172600CALL0 039.13FALSE00
2026-04-172700CALL0 038.05FALSE00
2026-04-172800CALL0 037.77FALSE00
2026-04-172905.1CALL0 137.55FALSE00
2026-04-171000PUT0 055.36FALSE00
2026-04-171050PUT0 053.43FALSE00
2026-04-171102.15PUT0 151.42FALSE00
2026-04-171152.7PUT0 150.21FALSE00
2026-04-171200PUT0 049.77FALSE00
2026-04-171250PUT0 049.59FALSE00
2026-04-171300PUT0 049.37FALSE00
2026-04-171350PUT0 049.27FALSE00
2026-04-171400PUT0 049.08FALSE00
2026-04-171450PUT0 048.94FALSE00
2026-04-171500PUT0 048.85FALSE00
2026-04-171550PUT0 048.43FALSE00
2026-04-171600PUT0 048.06FALSE00
2026-04-171650PUT0 047.73FALSE00
2026-04-171700PUT0 047.63FALSE00
2026-04-171750PUT0 047.35FALSE00
2026-04-171800PUT0 047.09FALSE00
2026-04-171850PUT0 046.5FALSE00
2026-04-171900PUT0 045.94FALSE00
2026-04-171950PUT0 045.58TRUE00
2026-04-172000PUT0 045.17TRUE00
2026-04-172100PUT0 044.24TRUE00
2026-04-172200PUT0 042.77TRUE00
2026-04-172300PUT0 041.89TRUE00
2026-04-172400PUT0 040.97TRUE00
2026-04-172500PUT0 039.45TRUE00
2026-04-172600PUT0 038.51TRUE00
2026-04-172700PUT0 037.97TRUE00
2026-04-172800PUT0 036.96TRUE00
2026-04-172900PUT0 036.12TRUE00
2026-06-18800CALL0 054.39TRUE00
2026-06-18850CALL0 055.09TRUE00
2026-06-18900CALL0 050.12TRUE00
2026-06-18950CALL0 050.28TRUE00
2026-06-181000CALL0 049.81TRUE00
2026-06-181050CALL0 051.84TRUE00
2026-06-181100CALL0 050.41TRUE00
2026-06-181150CALL0 050.98TRUE00
2026-06-181200CALL0 050.09TRUE00
2026-06-181250CALL0 049.83TRUE00
2026-06-181300CALL0 050TRUE00
2026-06-181350CALL0 049.13TRUE00
2026-06-181400CALL0 1049.32TRUE00
2026-06-181450CALL0 049.18TRUE00
2026-06-181500CALL0 048.78TRUE00
2026-06-1815551.5CALL0 248.17TRUE00
2026-06-1816049CALL0 247.36TRUE00
2026-06-1816536.9CALL0 247.3TRUE00
2026-06-1817037CALL0 1047.01TRUE00
2026-06-1817542.7CALL1 144.36TRUE42.70
2026-06-1818041.5CALL0 1546.27TRUE00
2026-06-1818531.8CALL0 145.82TRUE00
2026-06-1819035.5CALL0 1145.58TRUE00
2026-06-1819536.2CALL0 245.17FALSE00
2026-06-1820025.8CALL0 344.59FALSE00
2026-06-1821030CALL0 1843.69FALSE00
2026-06-1822020.6CALL0 242.88FALSE00
2026-06-1823018.6CALL0 442.26FALSE00
2026-06-182400CALL0 040.96FALSE00
2026-06-1825013.5CALL0 140.58FALSE00
2026-06-182600CALL0 040.06FALSE00
2026-06-182700CALL0 039.43FALSE00
2026-06-182800CALL0 039FALSE00
2026-06-182900CALL0 038.36FALSE00
2026-06-18800PUT0 065.25FALSE00
2026-06-18850PUT0 062.34FALSE00
2026-06-18900PUT0 059.71FALSE00
2026-06-18950PUT0 057.13FALSE00
2026-06-181000PUT0 054.9FALSE00
2026-06-181050PUT0 053.2FALSE00
2026-06-181100PUT0 051.3FALSE00
2026-06-181150PUT0 051.53FALSE00
2026-06-181200PUT0 050.59FALSE00
2026-06-181250PUT0 050.51FALSE00
2026-06-181309.08PUT0 050.15FALSE00
2026-06-181350PUT0 049.65FALSE00
2026-06-181400PUT0 049.16FALSE00
2026-06-181450PUT0 049FALSE00
2026-06-1815016.25PUT0 248.26FALSE00
2026-06-1815522.5PUT0 147.94FALSE00
2026-06-1816016.2PUT0 247.95FALSE00
2026-06-1816525.21PUT0 246.91FALSE00
2026-06-1817025.05PUT0 246.84FALSE00
2026-06-1817526.3PUT0 4446.55FALSE00
2026-06-1818033.3PUT0 946.06FALSE00
2026-06-1818535.6PUT0 846.17FALSE00
2026-06-181900PUT0 045.31FALSE00
2026-06-1819530.4PUT0 145.03TRUE00
2026-06-1820044.5PUT0 244.57TRUE00
2026-06-1821038.5PUT0 144.01TRUE00
2026-06-182200PUT0 042.98TRUE00
2026-06-182300PUT0 041.83TRUE00
2026-06-182400PUT0 041.17TRUE00
2026-06-182500PUT0 040.8TRUE00
2026-06-1826090.48PUT0 26940.04TRUE00
2026-06-182700PUT0 039.47TRUE00
2026-06-182800PUT0 038.53TRUE00
2026-06-182900PUT0 039.53TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm